ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

ClinicalTrials.gov ID: NCT03573297

Public ClinicalTrials.gov record NCT03573297. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:34 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Placebo-controlled, Randomized Withdrawal, Multicenter Clinical Trial Evaluating the Efficacy, Safety and Tolerability of Cariprazine in a Dose-reduction Paradigm in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features

Study identification

NCT ID
NCT03573297
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
901 participants

Conditions and interventions

Interventions

  • Cariprazine Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 14, 2018
Primary completion
Sep 4, 2022
Completion
Sep 4, 2022
Last update posted
Sep 27, 2023

2018 – 2022

United States locations

U.S. sites
46
U.S. states
16
U.S. cities
42
Facility City State ZIP Site status
Woodland International Research Group /ID# 232932 Little Rock Arkansas 72211
Woodland Research Northwest, LLC /ID# 232982 Rogers Arkansas 72758-6442
California Pharmaceutical Research Institute Inc. /ID# 232745 Anaheim California 92804
Advanced Research Center /ID# 233120 Anaheim California 92805
CI Trials /ID# 232642 Bellflower California 90706-7079
Synexus Clinical Research US Inc. /ID# 232743 Cerritos California 90703
ATP Clinical Research, Inc /ID# 232979 Costa Mesa California 92626-4607
ProScience Research Group /ID# 232945 Culver City California 90230-6632
Collaborative Neuroscience Research - Orange County /ID# 233077 Garden Grove California 92845
Behavioral Research Specialists, LLC /ID# 232980 Glendale California 91206-4261
Omega Clinical Trials LLC /ID# 233150 La Habra California 90631-3842
Synergy San Diego /ID# 232740 Lemon Grove California 91945-2956
Alliance for Research - Long Beach /ID# 232926 Long Beach California 90807
NRC Research Institute /ID# 232741 Orange California 92868
CNRI-San Diego /ID# 232748 San Diego California 92102
Artemis Institute for Clinical Research /ID# 233151 San Marcos California 92078-2338
Artemis Institute for Clinical Research /ID# 233152 San Marcos California 92078-2338
Collaborative Neuroscience Research LLC /ID# 232750 Torrance California 90502
Duplicate_MCB Clinical Research Centers LLC /ID# 232838 Colorado Springs Colorado 80910
Velocity Clinical Research - Hallandale Beach /ID# 232647 Hallandale Florida 33009-4427
Research Centers of America - Hollywood FL /ID# 232649 Hollywood Florida 33024-2706
CNS Healthcare - Jacksonville /ID# 233160 Jacksonville Florida 32256-6039
Meridien Research /ID# 232941 Maitland Florida 32751
Miami Lakes Medical Research /ID# 232826 Miami Lakes Florida 33016
University of South Florida /ID# 233093 Tampa Florida 33612
Synexus Clinical Research, Inc /ID# 232950 Atlanta Georgia 30328
Atlanta Center for Medical Research /ID# 232832 Atlanta Georgia 30331
CenExcel iResearch LLC /ID# 233045 Decatur Georgia 30030
Atlanta Behavioral Research, LLC /ID# 232935 Dunwoody Georgia 30338
NeuroPsychiatric Research Practice & Associate LTD /ID# 232840 Winfield Illinois 60190
Louisiana Clinical Research /ID# 232685 Shreveport Louisiana 71101
CBH Health LLC /ID# 232699 Gaithersburg Maryland 20877
St. Charles Psychiatric Associates - Midwest Research Group /ID# 232709 Saint Charles Missouri 63304
Duplicate_Altea Research Institute /ID# 232784 Las Vegas Nevada 89102
Hassman Research Institute /ID# 233088 Berlin New Jersey 08009
Neurobehavioral Research Inc /ID# 232791 Cedarhurst New York 11516
New Hope Clinical Research Inc. /ID# 232716 Charlotte North Carolina 28211
Richard Weisler MD, PA & Assoc /ID# 233049 Raleigh North Carolina 27609
Clinical Inquest Center Ltd /ID# 233043 Beavercreek Ohio 45431-2573
DUPLICATE_The Ohios State University Department of Psychiatry /ID# 232739 Columbus Ohio 43210
Midwest Clinical Research Center /ID# 232737 Dayton Ohio 45417
Sooner Clinical Research /ID# 232931 Oklahoma City Oklahoma 73112
Community Clinical Research Inc. /ID# 232672 Austin Texas 78754
Pillar Clinical Research LLC /ID# 232667 Richardson Texas 75080
Pillar Clinical Research LLC /ID# 232673 Richardson Texas 75080
Family Psychiatry of The Woodlands /ID# 232943 The Woodlands Texas 77381

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03573297, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 27, 2023 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03573297 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →